SCHEMBL739299

SCHEMBL739299

CC(=NC#N)NCc1ccc(Cl)nc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
KDM4E B2RXH2 2/20 0.45
GAA P10253 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
FAAH O00519 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
MAPT P10636 1/20 0.44
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ATM Q13315 1/20 0.40
CHRNB2 P17787 1/20 0.40
CHRNA4 P43681 1/20 0.40
CYP2C9 P11712 1/20 0.39
NAMPT P43490 1/20 0.39
OXTR P30559 1/20 0.39
AVPR1A P37288 1/20 0.39
CHRNA7 P36544 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
AR P10275 1/20 0.38
KDM1A O60341 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL739298 1.00 ALDH1A1 (0.45) ALDH1A1KDM4EGAASMN1; SMN2FAAH
SCHEMBL18633356 0.86 MEN1 (0.43) ALDH1A1KDM4EGAASMN1; SMN2L3MBTL1
SCHEMBL18623490 0.86 ALDH1A1 (0.45) ALDH1A1KDM4EGAASMN1; SMN2FAAH
SCHEMBL9134241 0.85 KDM4E (0.46) ALDH1A1KDM4EGAASMN1; SMN2FAAH
SCHEMBL7636310 0.83 ALDH1A1 (0.43) ALDH1A1KDM4EGAASMN1; SMN2FAAH
SCHEMBL7769528 0.83 ALDH1A1 (0.43) ALDH1A1KDM4EGAASMN1; SMN2FAAH
SCHEMBL7636313 0.83 ALDH1A1 (0.43) ALDH1A1KDM4EGAASMN1; SMN2FAAH
SCHEMBL7769526 0.83 ALDH1A1 (0.43) ALDH1A1KDM4EGAASMN1; SMN2FAAH
SCHEMBL9138502 0.82 KDM4E (0.42) ALDH1A1KDM4EGAASMN1; SMN2FAAH
SCHEMBL9138500 0.82 KDM4E (0.42) ALDH1A1KDM4EGAASMN1; SMN2FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049488-B1 N'-CYANO-N-ALKYL HALIDE IMIDE AMIDE DERIVATIVES BAYER IP GMBH (DE) 2015-12-09 EP disclosed
US-8138350-B2 N′-cyano-N-halogenalkylimidamide derivatives BAYER CROPSCIENCE AG (DE) 2012-03-20 US disclosed
US-8138350-B2 N′-cyano-N-halogenalkylimidamide derivatives BAYER CROPSCIENCE AG (DE) 2012-03-20 US disclosed
US-20100048646-A1 N'-Cyano-N-Halogenalkylimidamide Derivatives BAYER CROPSCIENCE AG (DE) 2010-02-25 US disclosed
US-20100048646-A1 N'-Cyano-N-Halogenalkylimidamide Derivatives BAYER CROPSCIENCE AG (DE) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048646-A1 N'-Cyano-N-Halogenalkylimidamide Derivatives NCLN, NISCH, DDT ALDH1A1 3834/4885KDM4E 2289/4885GAA 2313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.